• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viral subpopulation diversity in influenza virus isolates compared to clinical specimens

tetano

Editor, Senior Moderator
J Clin Virol. 2015 Jul;68:16-23. doi: 10.1016/j.jcv.2015.04.010. Epub 2015 Apr 11.
[h=1]Viral subpopulation diversity in influenza virus isolates compared to clinical specimens.[/h] Rutvisuttinunt W[SUP]1[/SUP], Chinnawirotpisan P[SUP]2[/SUP], Thaisomboonsuk B[SUP]3[/SUP], Rodpradit P[SUP]4[/SUP], Ajariyakhajorn C[SUP]5[/SUP], Manasatienkij W[SUP]6[/SUP], Simasathien S[SUP]7[/SUP], Shrestha SK[SUP]8[/SUP], Yoon IK[SUP]9[/SUP], Klungthong C[SUP]10[/SUP], Fernandez S[SUP]11[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza virus (IFV) isolates obtained from mammalian cell cultures are valuable reagents used for vaccine production, antigenic characterization, laboratory assays, and epidemiological and evolutionary studies. Complete genomic comparison of IFV isolates with their original clinical specimens provides insight into cell culture-driven genomic changes which may sequentially alter the virus phenotype.
[h=4]OBJECTIVES:[/h] The genome of the viral isolates and of the viruses in the clinical specimens was examined by deep sequencing in order to determine nucleotide heterogeneity (measured number of variances or numbers of mixed bases) as a marker for IFV population diversity.
[h=4]STUDY DESIGN:[/h] Clinical respiratory specimens were collected between July and October 2012 and identified by RT-PCR as positive for influenza A H3N2 or H1N1, or influenza B. The viruses in the clinical specimens were amplified using mammalian cell culture. Next generation sequencing (NGS) was used to investigate genomic differences between IFV isolates and their corresponding clinical specimens.
[h=4]RESULTS:[/h] There was less nucleotide heterogeneity in 5 of 6 viral isolates compared to the corresponding clinical specimens, especially for influenza B. A phylogenetic analysis of the hemagglutinin (HA) gene consensus sequences obtained from deep and Sanger sequencing showed that the viral isolates and their corresponding clinical specimens contained the same IFV strains with less than 5% pair-wise genetic distance.
[h=4]CONCLUSION:[/h] The IFV sequence data analysis detected a substantial decrease in nucleotide heterogeneity from clinical specimens to viral cultures in 5 out of 6 investigated cases.
Copyright ? 2015 The Authors. Published by Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Clinical specimens; Influenza; Next generation Sequencing; Variances; Viral isolates; Viral subpopulations

PMID: 26071329 [PubMed - in process] Free full text
 
Back
Top Bottom